Patents
Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044)
10/2003
10/29/2003EP1355946A1 Dna vaccines expressing hypervariable vh-cdr3 idiotipic determinants
10/29/2003EP1355924A2 Armed peptides
10/29/2003EP1355910A1 Formulation of boronic acid compounds
10/29/2003EP1355877A1 Process of obtaining compositions of stable lutein and lutein derivatives
10/29/2003EP1355682A2 Hydrogel wound dressing and the method of making and using the same
10/29/2003EP1355670A2 Enhanced stabilised plasmid-lipid particle-mediated transfection using endosomal membrane destabilisers
10/29/2003EP1355665A2 Treatment of juvenile rheumatioid arthritis by oral administration of pooled human immunoglobulin and an antacid
10/29/2003EP1355664A2 Methods employing and compositions containing plaque associated molecules for prevention and treatment of atherosclerosis
10/29/2003EP1355659A2 Use of compositions containing pdgf-bb for promoting angiogenesis
10/29/2003EP1355656A2 Red blood cell as vehicle for agent-membrane translocation sequence conjugate
10/29/2003EP1355652A2 Use of dinucleoside polyphosphate to stimulate removal of fluid in retinal disorders
10/29/2003EP1355647A2 The treatment of sexual dysfunction and cardiovascular disease with quinolinone enantiomers
10/29/2003EP1355636A1 Transdermal therapeutic system for administering non-steroidal antiphlogistic agents containing carboxyl groups, and a method for the production of the same
10/29/2003EP1355635A1 New film coating
10/29/2003EP1355634A2 Sn-38 lipid complexes and methods of use
10/29/2003EP1355633A1 New film coating
10/29/2003EP1355632A1 Amlodipine free base
10/29/2003EP1355631A2 Oral fast-melt formulation of a cyclooxygenase-2 inhibitor
10/29/2003EP1355630A2 Method of forming microparticles
10/29/2003EP1355629A1 Solid phase dispersion of quinolone- or naphthyridonecarboxylic acids
10/29/2003EP1355628A2 Stabilised polymeric aerosols for pulmonary gene delivery
10/29/2003EP1355627A1 Block-structure copolymer consisting of a saccharide segment bound to at least a biodegradable hydrophobic segment, and corresponding particles
10/29/2003EP1355626A2 Veterinary dermatologic composition
10/29/2003EP1355610A1 Device for inserting a needle-shaped body into living tissue
10/29/2003EP1355566A2 Local regional chemotherapy and radiotherapy using in situ hydrogel
10/29/2003EP1355537A1 Production of capsules and particles for improvement of food products
10/29/2003EP1251853B1 Transdermal therapeutic system for the administration of zaleplon
10/29/2003EP1214056B1 Topical suspension formulations containing ciprofloxacin and dexamethasone
10/29/2003EP1204429B1 Sustained release formulation of a peptide
10/29/2003EP1161230B1 Transdermal therapy system and method for producing the same
10/29/2003EP1105096B1 Injectable aqueous dispersions of propofol
10/29/2003EP1028714B1 Vitamin composition
10/29/2003EP1017370B1 MODIFIED RELEASE MULTIPLE-UNITS COMPOSITIONS OF NON-STEROID ANTI-INFLAMMATORY DRUG SUBSTANCES (NSAIDs)
10/29/2003EP0968000B1 Administrable compositions and methods for magnetic resonance imaging
10/29/2003EP0941066B1 Cationic lipid-nucleic acid complexes
10/29/2003EP0921787B1 ADMINISTRATION REGIMEN OF H+,K+-ATPase INHIBITORS
10/29/2003EP0892632B1 Compositions useful in the phototherapeutic treatment of proliferative skin disorders
10/29/2003EP0732920B1 Therapeutic agents containing thyroid hormones
10/29/2003EP0594803B1 Composition for reducing side-effects of a drug
10/29/2003CN2582603Y Special-shaped tablet
10/29/2003CN2582602Y Chinese medicine plaster film
10/29/2003CN1452650A Process for preparation of hydrophilic pressure sensitive adhesives having optimized adhesive properties
10/29/2003CN1452617A Acid-sensitive compounds, preparation and uses thereof
10/29/2003CN1452613A Amorphous torasemide modification
10/29/2003CN1452493A Method for cell adhesion and wound healing
10/29/2003CN1452485A Cannabinoid drugs
10/29/2003CN1452481A Pectin film compositions
10/29/2003CN1452480A Granular preparations for oral administration
10/29/2003CN1452479A Stable pharmaceutical solution formulations for pressurised metered dose inhalers
10/29/2003CN1452478A Pre-formed sheet devices suitable for topical application
10/29/2003CN1451443A Composition using bio-absorbable liquid polymer and medical apparatus
10/29/2003CN1451438A Sparagin injection using xylitol as isosmotic adjusting agent
10/29/2003CN1451433A Shenji ointment and preparing process thereof
10/29/2003CN1451428A Cough and asthma emplastrum
10/29/2003CN1451424A Preparation of catechu suppository
10/29/2003CN1451422A Chinese medicine for treating fundus oculi bleeding
10/29/2003CN1451421A ÔÇ£GukangÔÇØ patch
10/29/2003CN1451412A Refreshing tobacco and mustard chewing tablet
10/29/2003CN1451407A Process for producing Chinese medicine cell wall-broken micro powder
10/29/2003CN1451399A Superfine gastrodia tuber and American ginseng powder buccal lozenge
10/29/2003CN1451394A Superfine pearl powder and producing process thereof
10/29/2003CN1451386A Rifaximin soft capsule composition
10/29/2003CN1451382A Medicine for treating senile dementia and preparing process thereof
10/29/2003CN1451380A Percutaneous tobuterol patch
10/29/2003CN1451375A Pulse plug capsule for treating circabian rhythm disease and preparing process thereof
10/29/2003CN1451374A Double-layer slow release ibuprofen and pseudoephedrine hydrochloride tablet
10/29/2003CN1451373A Insoluble medicine tablet and preparing process thereof
10/29/2003CN1451372A Method for preparing medicine targeted liposome
10/29/2003CN1125654C Methods of preparing gas and gaseous precursor filled microspheres
10/29/2003CN1125653C Pharmaceutical formulations containing voriconazole
10/29/2003CN1125652C Wu Zuze
10/29/2003CN1125648C Patch for giving out smoking and its preparing process
10/29/2003CN1125640C Prophylactic and therapeutic agent for inflammatory intestinal diseases
10/29/2003CN1125639C Paroxetine Compsns
10/29/2003CN1125638C Stable slow release vitamin C preparation and its production process
10/29/2003CN1125636C Process for preparing particles containing oral 'beta' lactam activity
10/29/2003CN1125635C Enrofloxacine injection or infusion solutions
10/28/2003US6639113 Dispersing in an aqueous protecting colloids comprising at least one partially hydrolyzed soybean protein, drying by dehydration and desolventizing; use as additive to foods, pharmaceuticals and/or animal feeds
10/28/2003US6639105 For inhibiting tumor cell growth
10/28/2003US6639014 Multiblock biodegradable hydrogels for drug delivery and tissue treatment
10/28/2003US6638994 Aqueous suspension of nanoparticles comprising an agrochemical active ingredient
10/28/2003US6638987 Azeotrope-like compositions of tetrafluoroethane, pentafluoropropane and water
10/28/2003US6638981 Topical compositions and methods for treating pain
10/28/2003US6638971 Cocoa extract compounds and methods for making and using the same
10/28/2003US6638948 A free-flowing, amorphous paroxetine hydrochloride composition suitable as a therapeutic agent for premature ejaculation can be prepared by dissolving paroxetine free base in a hydrochloric acid-ethanol solution followed by
10/28/2003US6638932 Derivatives having HIV replication inhibiting properties. The present compounds differ from the known 1,3,5-triazines by structure and by their improved HIV replication inhibiting properties.
10/28/2003US6638918 Chitosan compositions
10/28/2003US6638915 Anti-viral composition
10/28/2003US6638913 Concentrated injection and infusion solution for intravenous administration
10/28/2003US6638767 Methods for delivering compounds into a cell
10/28/2003US6638740 Chromatography, elution, ion exchanging
10/28/2003US6638727 Intraductally administering an estrogen activity modulator
10/28/2003US6638621 Coated particles, methods of making and using
10/28/2003US6638613 Therapeutically enhanced saliva-activatable cellulosic product
10/28/2003US6638550 Method for coating solid confectionery centers
10/28/2003US6638540 Plant extracts for the treatment of increased bone resorption
10/28/2003US6638537 Emulsification with a long chain polymer surfactant and a short chain fatty acid surfactant; thermodynamic stability
10/28/2003US6638536 Storage stable allotropic organic compounds; sustained release, bioavailability, solid state crystallized
10/28/2003US6638535 Modified release formulations containing a hypnotic agent
10/28/2003US6638534 Preparation capable of releasing drug at target site in intestine